فرنسا - الفرنسية - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

arrow generiques - bétaméthasone 0 - solution - 0,05 % - pour un flacon de 30 ml > bétaméthasone 0,05 % - glucocorticoïde - usage systémique - classe pharmacothérapeutique : glucocorticoïde - usage systémique - code atc : h02ab01.ce médicament est un corticoïde.il est indiqué dans certaines maladies, où il est utilisé pour son effet anti-inflammatoire.

فرنسا - الفرنسية - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

eg labo - laboratoires eurogenerics - bétaméthasone 0 - solution - 0,05 % - pour un flacon de 30 ml > bétaméthasone 0,05 % - glucocorticoide - usage systemique - classe pharmacothérapeutique - code atc : h02ab01.glucocorticoide - usage systemique (h. hormones non sexuelles).ce médicament est un corticoïde. il est indiqué dans certaines maladies, où il est utilisé pour son effet anti-inflammatoire.

فرنسا - الفرنسية - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

zentiva france - bétaméthasone 0 - solution - 0,05 % - pour un flacon de 30 ml > bétaméthasone 0,05 % - glucocorticoïde - usage systémique. - classe pharmacothérapeutique : glucocorticoide - usage systemique.(h : hormones non sexuelles)ce médicament est un corticoïde (également appelé anti-inflammatoire stéroidien).ce médicament est réservé aux nourrissons et aux enfants.ce médicament est utilisé dans de nombreuses maladies, où il est utilisé pour son effet anti-inflammatoire. son action est utile dans le traitement de nombreuses affections inflammatoires ou allergiques.

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

cosette pharmaceuticals, inc. - betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - betamethasone 0.5 mg in 1 ml - topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. hypothalamic-pituitary-adrenal (hpa) axis suppression, cushing's syndrome, and intracranial hypertension have been reported in children receiving topical corticosteroids. manifestations of adrenal suppression in children include linear growth retardation, delayed weight gain, low plasma cortisol levels, and absence of response to acth stimulation. manifestations of intracranial hypertension include bulging fontanelles, headaches, and bilateral papilledema. administration of topical corticosteroids to pediatric patients should be limited to the least amount compatible with an effective therapeutic regimen. chronic corticosteroid therapy may interfere with the growth and development of children.

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

sti pharma llc - betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - betamethasone valerate 1.0 mg in 1 ml - topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of cortico-steroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

cosette pharmaceuticals, inc. - betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - betamethasone valerate 1.2 mg in 1 g - topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. pediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced hpa axis suppression and cushing's syndrome than mature patients because of a larger skin surface area to body weight ratio. hypothalamic-pituitary-adrenal (hpa) axis suppression, cushing's syndrome, and intracranial hypertension have been reported in children receiving topical corticosteroids. manifestations of adrenal suppression in children include linear growth retardation, delayed weight gain, low plasma cortisol levels, and absence of response to acth stimulation. manifestations of intracranial hypertension include bulging fontanelles, headaches, and bilateral papilledema. administration of topic

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

e. fougera & co. a division of fougera pharmaceuticals inc. - betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - betamethasone 1 mg in 1 g - topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

rebel distributors corp - betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone valerate - unii:9ifa5xm7r2) - betamethasone valerate 1 mg in 1 g - topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of cortico-steroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

remedyrepack inc. - betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - betamethasone 1 mg in 1 g - topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

e. fougera & co. a division of fougera pharmaceuticals inc. - betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - betamethasone 0.5 mg in 1 g - topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.